Compounds > 1,6-bis(cyclohexyloximinocarbonyl)hexane
Page last updated: 2024-11-03

1,6-bis(cyclohexyloximinocarbonyl)hexane and Colonic Neoplasms

1,6-bis(cyclohexyloximinocarbonyl)hexane has been researched along with Colonic Neoplasms in 1 studies

1,6-bis(cyclohexyloximinocarbonyl)hexane: selective inhibitor of canine platelet diglyceride lipase

Colonic Neoplasms: Tumors or cancer of the COLON.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Wasilewski, A1
Krajewska, U1
Owczarek, K1
Lewandowska, U1
Fichna, J1

Other Studies

1 other study available for 1,6-bis(cyclohexyloximinocarbonyl)hexane and Colonic Neoplasms

ArticleYear
Fatty acid amide hydrolase (FAAH) inhibitor PF-3845 reduces viability, migration and invasiveness of human colon adenocarcinoma Colo-205 cell line: an in vitro study.
    Acta biochimica Polonica, 2017, Volume: 64, Issue:3

    Topics: Adenocarcinoma; Amidohydrolases; Antineoplastic Agents; Benzodioxoles; Cell Line, Tumor; Cell Moveme

2017